Seguir
Raphael Aparecido Boschero
Raphael Aparecido Boschero
Researcher | Biochemical Engineer | PhD in Bioprocess Engineering and Biotechnology
Dirección de correo verificada de ourofino.com - Página principal
Título
Citado por
Citado por
Año
Cultivated meat: Recent technological developments, current market and future challenges
LAJ Letti, SG Karp, CFM Molento, BSO Colonia, RA Boschero, VT Soccol, ...
Biotechnology Research and Innovation Journal 5 (1), 0-0, 2021
132021
Alternative pharmaceutical formulation for oral administration of rifampicin
PCB Halicki, G Hädrich, R Boschero, LA Ferreira, A von Groll, ...
ASSAY and Drug Development Technologies 16 (8), 456-461, 2018
102018
Tuberculosis treatment facilitated by lipid nanocarriers: can inhalation improve the regimen?
G Hädrich, RA Boschero, AS Appel, M Falkembach, M Monteiro, ...
ASSAY and Drug Development Technologies 18 (7), 298-307, 2020
62020
Development of lipid nanocarriers for tuberculosis treatment: Evaluation of suitable excipients and nanocarriers
G Hädrich, GR Vaz, R Boschero, AS Appel, C Ramos, PCB Halicki, ...
Current Drug Delivery 18 (6), 770-778, 2021
42021
Produção de lipase microbiana a partir de resíduos de corvina
GPS Aguiar, VG Martins, PCC Martins, RA Boschero, ...
Revista de Engenharia e Tecnologia 10 (1), áginas 118-129, 2018
42018
High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design
NN Serena, RA Boschero, M Hospinal-Santiani, VD Pacce, JMDV Costa, ...
Journal of Immunological Methods 503, 113242, 2022
32022
A review on COVID-19 diagnosis tests approved for use in Brazil and the impact on pandemic control
JMD Vedova-Costa, ELP Ramos, RA Boschero, GN Ferreira, VT Soccol, ...
Brazilian Archives of Biology and Technology 64, e21200147, 2021
32021
ANTÍGENOS PEPTÍDEOS SINTÉTICOS PARA O DIAGNÓSTICO DO SARS-COV-2
V THOMAZ-SOCCOL, MH SANTIANI, CR SOCCOL, RA BOSCHERO, ...
BR Patent BR10,202,002,440, 0
2*
New age in vaccinology: the impact of the COVID-19 pandemic on third-generation vaccine development
ELP Ramos, JMD Vedova-Costa, VD Pacce, GN Ferreira, YCM Guzmán, ...
Biotechnology Research and Innovation Journal 5 (1), 0-0, 2021
2021
Formulation and Validation of Recombinant Antigens CFP10 and ESAT6 for Tuberculosis Diagnosis
LDCT Araujo, DE Rodriguez-Fernández, SG Karp, ES Marquez, ...
Brazilian Archives of Biology and Technology 64, e21210127, 2021
2021
Produção de biossurfactantes a partir de diferentes resíduos agroindustriais
CPH Gean Pablo Silva Aguiar, Vilásia Guimarães Martins, Paola Chaves Martins ...
Brazilian Journal of Food Research 9 (2), 2018
2018
USO DE PEPTÍDEO SINTÉTICO P.SC2.S118 PARA DIAGNÓSTICO DE COVID-19 USANDO PLATAFORMA DE IMUNODIAGNÓSTICO
V THOMAZ-SOCCOL, CR SOCCOL, ELP RAMOS, RA BOSCHERO, ...
BR Patent BR1,020,200,243,713, 0
PEPTÍDEO SINTÉTICO P.SC2.S.129 PARA IMUNODETECÇÃO DEANTICORPOS IGM, IGA E IGG CONTRA COVID-19
V THOMAZ-SOCCOL, CR SOCCOL, MH SANTIANI, RA BOSCHERO, ...
BR Patent BR1,020,200,243,802, 0
PEPTÍDEO SINTÉTICO P.SC2.S.132 PARA KIT ELISA DE AVIDEZNO DIAGNÓSTICO DE COVID-19
V THOMAZ-SOCCOL, ELP RAMOS, MH SANTIANI, RA BOSCHERO, ...
BR Patent BR1,020,200,243,900, 0
ANTÍGENO PEPTÍDEO SINTÉTICO P.SC2.S.309 APLICADO EM KIT E MÉTODO ELISA PARA DIAGNÓSTICO SOROLÓGICO DE COVID-19
V THOMAZ-SOCCOL, CR SOCCOL, RA BOSCHERO, MH SANTIANI, ...
BR Patent BR1,020,200,243,780, 0
KIT E MÉTODO ELISA PARA DIAGNÓSTICO DA TUBERCULOSEUTILIZANDO NOVO ANTÍGENO PEPTÍDEO SINTÉTICO P.Mt.PD.7
V THOMAZ-SOCCOL, NN SERENA, RA BOSCHERO, CR SOCCOL, ...
BR Patent BR10,202,001,989, 0
Influência do meio mineral na produção de Biossurfactantes
VGM FURG, PCM FURG, CPH FURG
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–17